Ontario woman who fought for cystic fibrosis drug recognized for increasing access [Globe and Mail, The (Toronto, Canada)]
Vertex Pharmaceuticals Incorporated (VRTX)
Last vertex pharmaceuticals incorporated earnings: 4/29 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.vrtx.com
Company Research
Source: Globe and Mail, The
Shay Conroy/The Globe and Mail The Canada Gairdner Awards Gala, held in October, celebrated achievements in biomedical research, from the discovery of stem cells to the development of mRNA vaccines. Two U.S.-based scientists - Michael Welsh and Paul Negulescu - received international honours for showcasing how science can spur life-saving interventions through their research on cellular and molecular mechanisms underpinning CF. The Gairdner Foundation said their work helped to transform CF from being a fatal disease to a manageable condition. Gairdner Award winners shine brighter than usual in a tough time for U.S. scientists “It makes me tear up,” Ms. Stavros said in an interview. “It's unfathomable that I'd be there that night. It felt like the definition of serendipitous.” When Ms. Stavros was born in the 1980s, many children living with CF did not live into adulthood. CF causes a build-up of mucus that primarily affects the digestive system and lungs. In the lungs, the
Show less
Read more
Impact Snapshot
Event Time:
VRTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VRTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VRTX alerts
High impacting Vertex Pharmaceuticals Incorporated news events
Weekly update
A roundup of the hottest topics
VRTX
News
- Vertex Pharmaceuticals (NASDAQ:VRTX) was given a new $564.00 price target on by analysts at Morgan Stanley.MarketBeat
- Why Analysts See Vertex Pharmaceuticals Story Shifting With New Pipeline Momentum and Valuation Debates [Yahoo! Finance]Yahoo! Finance
- Harding Loevner Global Equity's Views on Vertex Pharmaceuticals Incorporated (VRTX) [Yahoo! Finance]Yahoo! Finance
- Why Vertex Pharmaceuticals (VRTX) Stock Is Up Today [Yahoo! Finance]Yahoo! Finance
- Vertex Pharmaceuticals' Kidney Pipeline Seen as Growth Driver, Morgan Stanley Says [Yahoo! Finance]Yahoo! Finance
VRTX
Earnings
- 11/3/25 - Beat
VRTX
Sec Filings
- 12/5/25 - Form 4
- 12/5/25 - Form 4
- 12/5/25 - Form 4
- VRTX's page on the SEC website